India Leads Others In M&A Drug Maker Deals In Europe
This article was originally published in PharmAsia News
India's pharmaceutical industry outpaced its global colleagues in conducting deals with European drug makers for the first eight months of this year. Through August, Indian drug makers made 109 deals considered mergers or acquisitions since 2005, with 56 percent of them involving European firms. The United Kingdom was the primary target of Indian M&As. But there is some concern a rising trend of protectionism in Europe could deter the expansion there in the future. (Click here for more
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.